EUVIMEDEUVIMED entdecken
Crossref

Evaluation of SARS-CoV-2-Specific IgM and IgG Antibodies in Serum Samples of Patients with COVID-19

Neda Hampaiian, Asghar Tanomand iD

Viral Immunology · 2026

DOI: 10.1177/08828245251407701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viral Immunology, 2026. Verfasst von Neda Hampaiian und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Maragheh Branch, Islamic Azad University, Maragheh, Iran. Hauptthemen laut MEDLINE: Immunoglobulin M, Immunoglobulin G, COVID-19, Antibodies, Viral. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Several lines of evidence have shown high intraindividual and intraindividual variability in serum levels of IgM and IgG antibodies in response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The present study aimed to assess the levels of SARS-CoV-2-specific IgM and IgG antibodies in serum samples of laboratory-confirmed coronavirus disease 2019 (COVID-19) patients.

Methods

The study included 286 patients diagnosed with COVID-19, with 118 males and 168 females. Serum samples were taken from all subjects at two different time points, including 2 and 4 weeks after the onset of symptoms. Serological levels of SARS-CoV-2-specific IgM and IgG was assessed using the enzyme-linked immunosorbent assay technique. The Student’s t -test were used to compare the mean levels of SARS‐CoV‐2‐specific IgM and IgG between groups.

Results

We found that the mean serum levels of SARS‐CoV‐2‐specific IgM and IgG in COVID-19 patients were increased in 4 weeks after symptom onset compared to 2 weeks earlier, but it was not statistically significant ( p > 0.05). There was no significant sex-dependent difference in serological levels of SARS‐CoV‐2‐specific IgM and IgG ( p > 0.05).

Conclusion

Our findings suggest that the serum levels of SARS-CoV-2-specific IgM and IgG did not show significant differences depending on sex. Furthermore, serological levels of SARS‐CoV‐2‐specific IgM and IgG did not significantly differ between 2- and 4-weeks following illness onset.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin MImmunoglobulin GCOVID-19Antibodies, ViralSARS-CoV-2HumansMaleFemaleMiddle AgedAdultAgedYoung AdultAged, 80 and overEnzyme-Linked Immunosorbent Assay

Stichwörter der Autor:innen

Covid-19IgGIgMSARS-CoV-2coronaviruses

Substanzen

Immunoglobulin MImmunoglobulin GAntibodies, Viral

Autor:innen und Institutionen

  • Department of Microbiology, Maragheh Branch, Islamic Azad University, Maragheh, Iran.
  • Department of Microbiology, Faculty of Medicine, Maragheh University of Medical Science, Maragheh, Iran.

ORCID-Profile: Asghar Tanomand

Zitieren

APA

Hampaiian, N., & Tanomand, A. (2026). Evaluation of SARS-CoV-2-Specific IgM and IgG Antibodies in Serum Samples of Patients with COVID-19. Viral Immunology. https://doi.org/10.1177/08828245251407701

Vancouver

Hampaiian N, Tanomand A. Evaluation of SARS-CoV-2-Specific IgM and IgG Antibodies in Serum Samples of Patients with COVID-19. Viral Immunology. 2026. doi:10.1177/08828245251407701

BibTeX
@article{Hampaiian2026,
  author = {Hampaiian, Neda and Tanomand, Asghar},
  title = {Evaluation of SARS-CoV-2-Specific IgM and IgG Antibodies in Serum Samples of Patients with COVID-19},
  journal = {Viral Immunology},
  year = {2026},
  doi = {10.1177/08828245251407701}
}
Kostenlos starten →